A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer-Reference-Cited by-同舟云学术

A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

Published:2013 Issue:Suppl 6 Volume:14 Page:S5
ISSN:1471-2164
Container-title:BMC Genomics
language:en
Short-container-title:BMC Genomics

Author:

Barh Debmalya,Jain Neha,Tiwari Sandeep,Field John K,Padin-Iruegas Elena,Ruibal Alvaro,López Rafael,Herranz Michel,Bhattacharya Antaripa,Juneja Lucky,Viero Cedric,Silva Artur,Miyoshi Anderson,Kumar Anil,Blum Kenneth,Azevedo Vasco,Ghosh Preetam,Liloglou Triantafillos

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biotechnology

Reference60 articles.

1. Global cancer statistics

2. Five-year lung cancer survival

3. Lung cancer screening

4. An Overview of Lung Cancer Genomics and Proteomics

5. A serum circulating miRNA diagnostic test to identify asymptomatic high‐risk individuals with early stage lung cancer

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Analysis Reveals the Potential Roles of Transcription Factor Dp-1 in Lung Adenocarcinoma;World Journal of Oncology;2023-06

2. HMGA1 and FOXM1 Cooperate to Promote G2/M Cell Cycle Progression in Cancer Cells;Life;2023-05-22

3. HMGA1 gene expression level in cancer tissue and blood samples of non-small cell lung cancer (NSCLC) patients: preliminary report;Molecular Genetics and Genomics;2022-08-10

4. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma;International Journal of General Medicine;2022-07

5. Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis;International Journal of Molecular Sciences;2022-06-22